Shares of Anthem Inc (NYSE:ANTM) ended Tuesday session in green amid volatile trading. The shares closed up +1.22 points or 0.98% at $126.30 with 1.07 million shares getting traded. Post opening the session at $125.09, the shares hit an intraday low of $124.40 and an intraday high of $126.34 and the price vacillated in this range throughout the day. The company has a market cap of $32.76 billion and the numbers of outstanding shares have been calculated to be 263.17 million shares.
Anthem Inc (ANTM) operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
Shares of Eli Lilly and Co (NYSE:LLY) ended Tuesday session in green amid volatile trading. The shares closed up +1.36 points or 1.71% at $80.88 with 6.89 million shares getting traded. Post opening the session at $80.62, the shares hit an intraday low of $79.61 and an intraday high of $80.93 and the price vacillated in this range throughout the day. The company has a market cap of $89.14 billion and the numbers of outstanding shares have been calculated to be 1.10 billion shares.
On Sept. 27, 2016 Salesforce (CRM), the Customer Success Platform and world’s #1 CRM company, announced that Eli Lilly and Company (LLY) — a Fortune 500 company and global leader in healthcare — has expanded its use of the Salesforce Platform to develop more innovative and intuitive apps that are designed to personalize patient support programs, unite care teams and ultimately improve patient outcomes.
Since 1876, Lilly has succeeded in helping people live longer, healthier and more active lives by creating high-quality medicines that meet real patient needs. However, expectations have changed tremendously in recent years, as many patients want their providers and pharmaceutical companies to connect with them through mobile, social and cloud technologies.
To address evolving patient needs, Lilly turned to Salesforce to help launch more than 50 apps over the last two years. These are internal and external facing apps that Lilly has used to better understand patient insights and engage in a way patients prefer. For example, Lilly TrialGuide helps patients learn about clinical trials, find one that’s right for them and connect with the clinic. With its expanded use of the Salesforce Platform, Lilly is doubling down on its efforts to develop apps that will lead to more relevant and meaningful touch-points along every step of the patient journey.